Predictors of relapse and overall survival in Philadelphia chromosome–positive acute lymphoblastic leukemia after transplantation
Open Access
- 31 March 2003
- journal article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 9 (3) , 206-212
- https://doi.org/10.1016/s1083-8791(03)70011-1
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Outcome of Treatment in Children with Philadelphia Chromosome–Positive Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 2000
- Long-term follow-up of 23 patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with allogeneic bone marrow transplant in first complete remissionLeukemia, 1999
- Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapiesCancer, 1998
- Marrow Transplants From Unrelated Donors for Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic LeukemiaBlood, 1997
- Philadelphia chromosome in relapsed childhood acute lymphoblastic leukemia: a matched-pair analysis. Berlin-Frankfurt-Münster Study Group.Journal of Clinical Oncology, 1997
- Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens.Journal of Clinical Oncology, 1993
- Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemiaBlood, 1992
- Variable Philadelphia breakpoints and potential lineage restriction of bcr rearrangement in acute lymphoblastic leukemiaBlood, 1988
- Chromosomal abnormalities identify high-risk and low-risk patients with acute lymphoblastic leukemiaBlood, 1986
- Structural organization of the bcr gene and its role in the Ph′ translocationNature, 1985